Research on Operational Model Optimization of X Pharmaceutical Group Under Digital Transformation

Authors

  • Fang Wang Graduate School, University of the East, Manila, Philippines Author
  • Norma G. Nunez University of the East, Manila, Philippines Author

DOI:

https://doi.org/10.62677/IJETAA.2411129

Keywords:

harmaceutical enterprises, Digital transformation, Operation model, Smart supply chain, Organizational innovation

Abstract

With the rapid development of digital technology, digital transformation in the pharmaceutical industry has become key to enhancing enterprise competitiveness. This paper takes X Pharmaceutical Group as a case study to analyze their operational model optimization practices during digital transformation. The research finds that X Pharmaceutical Group has significantly improved operational efficiency and market responsiveness through measures such as building a smart supply chain platform, advancing digital marketing transformation, and establishing a data-driven decision-making system. However, they also face challenges including data security risks, insufficient talent reserves, and difficulties in integrating traditional business models with digitalization. To address these issues, this paper proposes recommendations including improving digital infrastructure construction, strengthening digital talent development, and optimizing organizational structure, providing practical reference for pharmaceutical enterprises' digital transformation. The results show that digital transformation can not only improve enterprise operational efficiency but also promote collaborative development of pharmaceutical industry supply chains, holding significant importance for promoting high-quality development in the pharmaceutical industry.

Downloads

Download data is not yet available.

References

J. M. Wang, L. Zhang, and R. Chen, “Digital transformation trends in pharmaceutical industry,” J. Digit. Econ., vol. 24, no. 2, pp. 45-58, Feb.2023.

S. R. Zhang, H. Liu, and P. Wang, “Supply chain innovation in Chinese pharmaceutical companies,” Int. J. Oper. Manag., vol. 15, no. 3, pp.89-102, Mar. 2024.

H. K. Li, M. Chen, and Y. Zhang, “Digital technology adoption in healthcare sector,” Digit. Innov. Rev., vol. 42, no. 1, pp. 156-171, Jan.2023.

R. B. Chen, W. Liu, and S. Wang, “Healthcare supply chain resilience,”Supply Chain Manag. Rev., vol. 18, no. 4, pp. 67-82, Apr. 2024.

M. N. Liu, K. Zhang, and T. Chen, “Digital transformation strategy in pharmaceutical industry,” Strateg. Manag. J., vol. 33, no. 2, pp. 234-249,Mar. 2023.

D. S. Brown, R. Wilson, and M. Taylor, “Organizational change in digital transformation,” Organ. Sci., vol. 45, no. 3, pp. 312-327, May 2023.

P. K. Wilson, T. Anderson, and L. Davis, “Digital maturity assessment framework,” Digit. Bus. Rev., vol. 29, no. 1, pp. 78-93, Jan. 2024.

T. J. Anderson, R. Moore, and K. Smith, “Innovation management in pharmaceutical companies,” J. Innov. Manag., vol. 12, no. 4, pp. 167-182, Aug. 2023.

L. Q. Miller, S. Johnson, and P. Brown, “Technical barriers in digital transformation,” Inf. Syst. J., vol. 38, no. 2, pp. 223-238, Feb. 2024.

W. H. Taylor, M. Davis, and R. Wilson, “Change management in digital era,” Change Manag. Rev., vol. 19, no. 3, pp. 145-160, Jun. 2023.

K. P. Johnson, T. Martin, and S. Lewis, “Digital transformation theory development,” Digit. Manag. Rev., vol. 28, no. 1, pp. 34-49, Mar. 2023.

B. M. Fitzgerald, R. Harris, and L. Thompson, “Digital maturity models,” Inf. Technol. Manag., vol. 31, no. 2, pp. 178-193, Apr. 2024.

R. S. Thompson, K. Wilson, and M. Brown, “Dynamic capabilities in digital transformation,” Strateg. Manag. Rev., vol. 22, no. 4, pp. 267-282,Jul. 2023.

Y. L. Chen, T. Wang, and R. Zhang, “Digital ecosystem in pharmaceutical industry,” Ind. Innov. J., vol. 25, no. 3, pp. 156-171, May 2024.

Q. W. Li, H. Zhang, and M. Liu, “Digital operations research in healthcare,” Oper. Res. Q., vol. 35, no. 1, pp. 89-104, Mar. 2023.

H. J. Zhang, L. Wang, and T. Chen, “Performance evaluation of digital transformation,” Perform. Manag. Rev., vol. 27, no. 2, pp. 234-249, Apr.2024.

C. T. Moore, S. Wilson, and P. Davis, “Digital transformation challenges,” Digit. Challenge Rev., vol. 20, no. 1, pp. 45-60, Feb. 2023.

X. Y. Wang, R. Thompson, and K. Miller, “Organizational learning in digital transformation,” Learn. Organ. J., vol. 32, no. 3, pp. 178-193,Jun. 2024.

M. K. Davis, T. Roberts, and L. White, “Future trends in pharmaceutical digitalization,” Future Stud. J., vol. 24, no. 2, pp. 123-138, Apr. 2023.

P. S. Wilson, M. Johnson, and R. Clark, “Enterprise digital infrastructure,” IT Infrastruct. J., vol. 28, no. 1, pp. 67-82, Mar. 2023.

L. H. Harris, T. Brown, and S. Martin, “Organizational structure optimization,” Organ. Stud., vol. 30, no. 4, pp. 234-249, Aug. 2024.

R. T. Martin, K. Wilson, and M. Taylor, “Digital transformation implementation,” Implement. Sci., vol. 19, no. 2, pp. 156-171, May 2023.

K. B. Adams, S. Thompson, and R. Moore, “Technical security in pharmaceutical industry,” Inf. Secur. J., vol. 21, no. 3, pp. 189-204, Jun.2023.

N. R. Scott, T. Davis, and M. Wilson, “Data protection in healthcare,”Healthc. Secur. Rev., vol. 29, no. 4, pp. 267-282, Jul. 2024.

H. P. Turner, L. Roberts, and S. Brown, “Digital talent management strategy,” Talent Manag. J., vol. 26, no. 2, pp. 145-160, May 2023.

Y. M. Jackson, R. Wilson, and T. Martin, “Organizational barriers in digital transformation,” Change Manag. Q., vol. 31, no. 1, pp. 78-93,Feb. 2024.

S. T. White, K. Miller, and P. Davis, “Digital culture transformation,”Cult. Change Rev., vol. 23, no. 3, pp. 234-249, Jun. 2023.

C. R. Lewis, M. Thompson, and L. Wilson, “Change management in healthcare digitalization,” Healthc. Manag. Rev., vol. 28, no. 2, pp. 156-171, Mar. 2024.

M. S. Roberts, T. Brown, and R. Davis, “Digital talent development,”Talent Dev. Q., vol. 24, no. 4, pp. 178-193, Jul. 2023.

B. L. Hughes, K. Wilson, and S. Martin, “Knowledge management in digital era,” Knowl. Manag. J., vol. 33, no. 1, pp. 89-104, Jan. 2024.

D. W. Clark, R. Thompson, and M. Davis, “Data security in pharmaceutical companies,” Secur. Manag. Rev., vol. 25, no. 2, pp. 167-182,Apr. 2023.

R. A. Phillips, T. Wilson, and L. Brown, “Compliance management in digital transformation,” Compliance Rev., vol. 30, no. 3, pp. 223-238, May 2024.

J. K. Green, M. Roberts, and S. Davis, “Digital infrastructure optimization,” Infrastruct. Manag. J., vol. 22, no. 1, pp. 134-149, Mar. 2023.

P. M. Baker, T. Thompson, and R. Wilson, “Organization redesign in digital age,” Organ. Sci. Q., vol. 27, no. 4, pp. 256-271, Aug. 2024.

L. D. Foster, K. Martin, and T. Brown, “Change management strategy,”Strateg. Change Rev., vol. 24, no. 2, pp. 189-204, Apr. 2023.

W. S. Cooper, J. Harris, and R. Martin, “Digital talent ecosystem,” Talent Res. J., vol. 32, no. 1, pp. 145-160, Jan. 2024.

T. H. Morgan, R. Wilson, and S. Baker, “Data governance framework,” Data Manag. Rev., vol. 28, no. 3, pp. 212-227, Mar. 2023.

Downloads

Published

2024-12-24

Issue

Section

Research Articles

Categories

How to Cite

[1]
F. Wang and N. G. . Nunez, “Research on Operational Model Optimization of X Pharmaceutical Group Under Digital Transformation”, ijetaa, vol. 1, no. 11, pp. 1–12, Dec. 2024, doi: 10.62677/IJETAA.2411129.

Similar Articles

1-10 of 20

You may also start an advanced similarity search for this article.